These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Lack of efficacy of thrombopoietin and granulocyte colony-stimulating factor after high dose total-body irradiation and autologous stem cell or bone marrow transplantation in rhesus monkeys. Neelis KJ, Dubbelman YD, Wognum AW, Thomas GR, Eaton DL, Egeland T, Wagemaker G. Exp Hematol; 1997 Sep; 25(10):1094-103. PubMed ID: 9293907 [Abstract] [Full Text] [Related]
25. Randomized, blinded, placebo-controlled phase I trial of pegylated recombinant human megakaryocyte growth and development factor with filgrastim after dose-intensive chemotherapy in patients with advanced cancer. Basser RL, Rasko JE, Clarke K, Cebon J, Green MD, Grigg AP, Zalcberg J, Cohen B, O'Byrne J, Menchaca DM, Fox RM, Begley CG. Blood; 1997 May 01; 89(9):3118-28. PubMed ID: 9129014 [Abstract] [Full Text] [Related]
26. PEG-rHuMGDF ameliorates thrombocytopenia in carboplatin-treated rats without inducing myelofibrosis. Ide Y, Harada K, Imai A, Yanagida M. Int J Hematol; 1999 Aug 01; 70(2):91-6. PubMed ID: 10497847 [Abstract] [Full Text] [Related]
27. Effect of intraperitoneally administered recombinant murine granulocyte-macrophage colony-stimulating factor (rmGM-CSF) on the cytotoxic potential of murine peritoneal cells. Klimp AH, Regts J, Scherphof GL, de Vries EG, Daemen T. Br J Cancer; 1999 Jan 01; 79(1):89-94. PubMed ID: 10408698 [Abstract] [Full Text] [Related]
29. Prospective, randomized trial of sequential interleukin-3 and granulocyte- or granulocyte-macrophage colony-stimulating factor after standard-dose chemotherapy in cancer patients. Palmeri S, Leonardi V, Danova M, Porta C, Ferrari S, Fincato G, Citarrella P. Haematologica; 1999 Nov 01; 84(11):1016-23. PubMed ID: 10553163 [Abstract] [Full Text] [Related]
30. Mobilization of peripheral blood progenitor cells by Betafectin PGG-Glucan alone and in combination with granulocyte colony-stimulating factor. Patchen ML, Liang J, Vaudrain T, Martin T, Melican D, Zhong S, Stewart M, Quesenberry PJ. Stem Cells; 1998 Nov 01; 16(3):208-17. PubMed ID: 9617896 [Abstract] [Full Text] [Related]
31. Effects of recombinant human granulocyte-macrophage colony-stimulating factor on platelet survival and activation using a nonhuman primate model. Tomer A, Stahl CP, McClure HM, Anderson DC, Myers LA, Liehl E, Winton EF. Exp Hematol; 1993 Nov 01; 21(12):1577-82. PubMed ID: 8405239 [Abstract] [Full Text] [Related]
37. Use of PEG-rHuMGDF in platelet engraftment after autologous stem cell transplantation. Fields KK, Crump M, Bence-Bruckler I, Bernstein S, Williams S, Frankel S, Miller A, Demetri G, Nabholtz JM, Cruickshank S, Lill M. Bone Marrow Transplant; 2000 Nov 01; 26(10):1083-8. PubMed ID: 11108307 [Abstract] [Full Text] [Related]
38. Megakaryopoiesis in vitro in myelodysplastic syndromes and acute myeloid leukaemia: effect of pegylated recombinant human megakaryocyte growth and development factor in combination with other growth factors. Liu Yin JA, Adams JA, Brereton ML, Hann A, Harrison BD, Briggs M. Br J Haematol; 2000 Mar 01; 108(4):743-6. PubMed ID: 10792278 [Abstract] [Full Text] [Related]
39. Effects of polyethylene glycol-conjugated recombinant human megakaryocyte growth and development factor on platelet counts after chemotherapy for lung cancer. Fanucchi M, Glaspy J, Crawford J, Garst J, Figlin R, Sheridan W, Menchaca D, Tomita D, Ozer H, Harker L. N Engl J Med; 1997 Feb 06; 336(6):404-9. PubMed ID: 9010146 [Abstract] [Full Text] [Related]
40. Differential effect of erythropoietin and GM-CSF on megakaryocytopoiesis from primitive bone marrow cells in serum-free conditions. Cardier JE, Erickson-Miller CL, Murphy MJ. Stem Cells; 1997 Feb 06; 15(4):286-90. PubMed ID: 9253112 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]